Divalproex Sodium Tablet, Delayed Release
Product Images NDC 55154-5633

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55154-5633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag Label (4fc50afb 67f3 4bf3 9ec3 Cc12734f47fd 00)

Bag Label (4fc50afb 67f3 4bf3 9ec3 Cc12734f47fd 00)
This is a description of a medication called Divalproex Sodium that comes in a unit dose package containing 10 delayed-release tablets with a strength of 500 mg, each containing Valproic Acid Activity. The tablets must be swallowed whole and not chewed. It is suggested to store the medication at a temperature between 20 to 25° C, with excursions permitted to 15 to 30° C. The Medication Guide should be dispensed to every patient by the pharmacist. It is warned that this unit dose package is not child-resistant, so it is not intended for household usage. Lastly, the medication is manufactured by Upsher-Smith Laboratories, LLC and distributed by Cardinal Health.*
FDA Label Image

Chemical Structure (Divalproex 01)

Chemical Structure (Divalproex 01)
FDA Label Image

Figure 1 (Divalproex 02)

Figure 1 (Divalproex 02)
FDA Label Image

Figure 2 (Divalproex 03)

Figure 2 (Divalproex 03)
FDA Label Image

Figure 3 (Divalproex 04)

Figure 3 (Divalproex 04)
FDA Label Image

Figure 4 (Divalproex 05)

Figure 4 (Divalproex 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.